Toggle navigation
ABOUT US
Overview
Leadership
Governance
Board
Our purpose
Global footprint
Our global reach
Partners
Press releases
News
Our science
Drug optimization
Lauriad
®
technology
Overview
How it works
Scientific publications
Lauriad
®
applications
OUR MEDICINES
PIPELINE
Commercialized medicines
Sitavig
®
Loramyc
®
PARTNER WITH US
Commercial & Industrial partners
Academic & Research collaborations
Careers
Working at Vectans Pharma
Join us
CONTACT
Nomination of François Boutignon as Chief Innovation and Technology Officer
Read the press release
Last news
OTC switch approval in Sweden for Virono®50mg
A brighter horizon for Oropharyngeal Candidiasis patients in Argentina
Loramyc® Marketing autorization granted in mexico !
Happy 2024 !
OTC switch approval in Finland for Sitavig® 50mg
230 Bureaux de la colline
92213 Saint-Cloud
France
contact@vectans.com
FOLLOW US
Copyright © VECTANS PHARMA
Legal notices and privacy policy